TITAN MEDICAL INC (TMD.CA) Fundamental Analysis & Valuation

TSX:TMD • CA88830X8199

Current stock price

0.8 CAD
-0.04 (-4.76%)
Last:

This TMD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TMD.CA Profitability Analysis

1.1 Basic Checks

  • TMD had negative earnings in the past year.
  • TMD had a negative operating cash flow in the past year.
  • In the past 5 years TMD reported 4 times negative net income.
  • TMD had negative operating cash flow in 4 of the past 5 years.
TMD.CA Yearly Net Income VS EBIT VS OCF VS FCFTMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

  • With a Return On Assets value of -111.81%, TMD is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • TMD has a Return On Equity (-184.94%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -111.81%
ROE -184.94%
ROIC N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TMD.CA Yearly ROA, ROE, ROICTMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K -2K -3K

1.3 Margins

  • In the last couple of years the Operating Margin of TMD has grown nicely.
  • TMD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TMD.CA Yearly Profit, Operating, Gross MarginsTMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TMD.CA Health Analysis

2.1 Basic Checks

  • TMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, TMD has more shares outstanding
  • The debt/assets ratio for TMD has been reduced compared to a year ago.
TMD.CA Yearly Shares OutstandingTMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
TMD.CA Yearly Total Debt VS Total AssetsTMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

  • TMD has an Altman-Z score of -81.60. This is a bad value and indicates that TMD is not financially healthy and even has some risk of bankruptcy.
  • TMD's Altman-Z score of -81.60 is on the low side compared to the rest of the industry. TMD is outperformed by 81.25% of its industry peers.
  • A Debt/Equity ratio of 0.22 indicates that TMD is not too dependend on debt financing.
  • The Debt to Equity ratio of TMD (0.22) is better than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -81.6
ROIC/WACCN/A
WACC7.75%
TMD.CA Yearly LT Debt VS Equity VS FCFTMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

2.3 Liquidity

  • A Current Ratio of 3.73 indicates that TMD has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.73, TMD belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
  • TMD has a Quick Ratio of 3.73. This indicates that TMD is financially healthy and has no problem in meeting its short term obligations.
  • TMD's Quick ratio of 3.73 is amongst the best of the industry. TMD outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 3.73
TMD.CA Yearly Current Assets VS Current LiabilitesTMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. TMD.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 65.90% over the past year.
  • Looking at the last year, TMD shows a very negative growth in Revenue. The Revenue has decreased by -94.31% in the last year.
  • TMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.11% yearly.
EPS 1Y (TTM)65.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.99%
Revenue 1Y (TTM)-94.31%
Revenue growth 3Y-4.11%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TMD.CA Yearly Revenue VS EstimatesTMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 5M 10M 15M 20M
TMD.CA Yearly EPS VS EstimatesTMD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. TMD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • TMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMD.CA Price Earnings VS Forward Price EarningsTMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMD.CA Per share dataTMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TMD.CA Dividend Analysis

5.1 Amount

  • TMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

TMD.CA Fundamentals: All Metrics, Ratios and Statistics

TITAN MEDICAL INC

TSX:TMD (11/22/2024, 7:00:00 PM)

0.8

-0.04 (-4.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07
Earnings (Next)N/A
Inst Owners0.46%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.40M
Revenue(TTM)950.00K
Net Income(TTM)-5.05M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.6
P/FCF N/A
P/OCF N/A
P/B 9.26
P/tB 9.26
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.03
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -111.81%
ROE -184.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 96.67%
Cap/Sales 12.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 3.73
Altman-Z -81.6
F-Score1
WACC7.75%
ROIC/WACCN/A
Cap/Depr(3y)113.76%
Cap/Depr(5y)424.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-94.31%
Revenue growth 3Y-4.11%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.67%
EBIT growth 3Y28.68%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.06%
OCF growth 3YN/A
OCF growth 5YN/A

TITAN MEDICAL INC / TMD.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TITAN MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to TMD.CA.


What is the valuation status of TITAN MEDICAL INC (TMD.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to TITAN MEDICAL INC (TMD.CA). This can be considered as Overvalued.


How profitable is TITAN MEDICAL INC (TMD.CA) stock?

TITAN MEDICAL INC (TMD.CA) has a profitability rating of 1 / 10.